Research

February 9, 2026

AI finds patient-level statin barriers in clinical notes

A novel AI framework found documented intolerance to statins in 6.4% of all adult patients, contraindications in 0.7%, and statin deferral in 2.9%.

February 9, 2026

Vanderbilt research uncovers new clue to insulin resistance

The latest findings could lead to more targeted ways to increase insulin-stimulated glucose uptake by muscle and exercise tolerance.

Members of the Vanderbilt Health team are evaluating the efficacy of the immunomodulatory drug baricitinib for treating the persistent neurological and cardiopulmonary symptoms of long COVID. (photo by Donn Jones)
February 6, 2026

Vanderbilt Health to lead expanded multisite study of immunomodulation in long COVID

The public health burden of long COVID is estimated to be the largest seen from an emerging disease in the past century, yet there remain no effective interventions.

February 6, 2026

New analytical approach identifies novel risk genes for colorectal cancer

The study advances understanding of risk for colon and rectal cancers and points to targets for developing new treatments.

February 5, 2026

‘Liberation’ from acute dialysis may enhance recovery of kidney function

Researchers at Vanderbilt Health and three other centers compared conventional dialysis to a conservative dialysis strategy.

February 4, 2026

Vanderbilt Health’s Vineet Agrawal, Fabian Bock among 2026 ASCI Young Physician-Scientist awardees

Since 2014, 27 Vanderbilt faculty members have received the annual award, which recognizes “notable achievements” by researchers early in their first faculty appointments.